SSKN - メラ・サイエンス (Strata Skin Sciences Inc.)


   The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study  2020/03/06 13:49:43 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 5.) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Aytu Bioscience Inc (NASDAQ: AYTU ) Celcuity Inc (NASDAQ: CELC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) Glaukos Corp (NYSE: GKOS ) Lantheus Holdings Inc (NASDAQ: LNTH ) Mylan NV (NASDAQ: MYL ) Neurometrix Inc (NASDAQ: NURO ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Orthofix Medical Inc (NASDAQ: OFIX ) Passage Bio Inc (NASDAQ: PASG ) (went public last week) Polarityte Inc (NASDAQ: PTE ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) (reacted to first-quarter results) T2 Biosystems Inc (NASDAQ: TTOO ) Xeris …
   The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies  2020/03/04 12:37:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) EXACT Sciences Corporation (NASDAQ: EXAS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Midatech Pharma PLC-ADR (NASDAQ: MTP )(began trading on a reverse split adjusted basis) Mylan NV (NASDAQ: MYL ) Neuronetics Inc (NASDAQ: STIM )(announced its fourth-quarter results) Passage Bio Inc (NASDAQ: PASG )(IPOed last week) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TransMedics Group Inc (NASDAQ: TMDX )(reported its fourth-quarter results) VIVUS, Inc. (NASDAQ: VVUS ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd (NYSE: TAK ) said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection.
   The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion  2020/02/21 12:46:22 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Arcus Biosciences Inc (NYSE: RCUS ) BELLUS Health Inc (NASDAQ: BLU ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Masimo Corporation (NASDAQ: MASI ) (announced its fourth-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Relmada Therapeutics Inc (NASDAQ: RLMD ) Repro-Med Systems, Inc. (NASDAQ: KRMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) (announced $287.5-million debt offering) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Feb. 13) Scpharmaceuticals Inc (NASDAQ: SCPH ) Soligenix, Inc.
   The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study  2019/08/22 11:18:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 21) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) AstraZeneca plc (NYSE: AZN )(advanced despite reporting negative results for its lung cancer drug) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cardiovascular Systems Inc (NASDAQ: CSII ) DexCom, Inc. (NASDAQ: DXCM ) Lipocine Inc (NASDAQ: LPCN ) NextCure Inc (NASDAQ: NXTC ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR ) Recro Pharma Inc (NASDAQ: REPH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 21) Abeona Therapeutics Inc (NASDAQ: ABEO ) Artelo Biosciences Inc (NASDAQ: ARTL ) Avanos Medical Inc (NYSE: AVNS ) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) KemPharm Inc (NASDAQ: KMPH ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nektar Therapeutics (NASDAQ:NKT) Obalon Therapeutics Inc (NASDAQ: OBLN ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) Stocks In Focus ViiV's Long-Acting HIV Drug Combo Aces Late-Stage Trial ViiV Healthcare, majority owned by GlaxoSmithKline plc (NYSE: GSK ), with Pfizer Inc.
   STRATA Skin receives delinquency notice from Nasdaq  2019/05/20 10:19:01 Seeking Alpha
   January Barometer Shows Momentum And Forensic Negative Portfolios Are The Hottest  2019-01-31
The Portfolio Barometer Using an inductive portfolio model approach that goes where the types of returns in the market are strongest, I monitor different fundamental, value, momentum, forensic, and anomaly portfolios from financial research to create a portfolio barometer. This article conti…